Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) may have the potential to lower the risk of osteoarthritis through an anti‐inflammatory mechanism. This study compared the risks of new‐onset osteoarthritis and joint replacement… Click to show full abstract
Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) may have the potential to lower the risk of osteoarthritis through an anti‐inflammatory mechanism. This study compared the risks of new‐onset osteoarthritis and joint replacement surgery between new users of SGLT2is and new users of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs).
Keywords:
cotransporter inhibitors;
glucose cotransporter;
like peptide;
peptide receptor;
sodium glucose;
glucagon like
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!